The FDA recently updated its 2017 safety communication warning that biotin—a common dietary supplement also known as vitamin B7—can seriously interfere with certain lab tests. The update was prompted by continued reports of adverse events linked with incorrect lab results stemming from biotin interference.
Sancar F. Update on Biotin Interference With Troponin Tests. JAMA. 2019;322(23):2277. doi:10.1001/jama.2019.20129
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: